Zoledronic acid reduces rates of new clinical fractures after hip fracture repair
Vol: 2| Issue: 7| Number:166| ISSN#: 2564-2537
OE Level Evidence:1
Journal Level of Evidence:N/A
Zoledronic Acid and Clinical Fractures and Mortality after Hip FractureN Engl J Med. 2007 Nov 1;357(18):1799-809. Epub 2007 Sep 17
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
2127 patients were randomized to one of two groups to examine the rates of new clinical fractures after hip fracture repair. The first group received an annual infusion of zoledronic acid (a potent bisphosphonate), while the second group received a placebo. Results indicated that an annual infusion of zoledronic acid is associated with reduced rates of new clinical fractures and subsequently, morb...
Join the Conversation
Please Login or Join to leave comments.